atc_code
stringlengths 1
7
| atc_name
stringlengths 3
95
| ddd
float64 0.1
800
⌀ | uom
stringclasses 10
values | adm_r
stringclasses 18
values | note
stringclasses 96
values |
---|---|---|---|---|---|
A11AA02 | multivitamins and calcium | null | null | null | null |
N06AA08 | dibenzepin | 0.3 | g | O | null |
R03AC13 | formoterol | 24 | mcg | Inhal.aerosol | null |
N02BA09 | dipyrocetyl | 3 | g | O | null |
D07BC01 | betamethasone and antiseptics | null | null | null | null |
N05BX | Other anxiolytics | null | null | null | null |
A11CC03 | alfacalcidol | 1 | mcg | P | null |
C03AB06 | trichlormethiazide and potassium | 4 | mg | O | Refers to trichlormethiazide |
G03GA07 | lutropin alfa | 75 | U | P | null |
R05DB17 | droxypropine | null | null | null | null |
R06AE | Piperazine derivatives | null | null | null | null |
A02BC53 | lansoprazole, combinations | null | null | null | null |
H02AB10 | cortisone | 37.5 | mg | O | null |
J01GB | Other aminoglycosides | null | null | null | null |
J01CA09 | azlocillin | 12 | g | P | null |
J01DD06 | latamoxef | 4 | g | P | null |
C09AA11 | spirapril | 6 | mg | O | null |
G04BE52 | papaverine, combinations | null | null | null | null |
A16AX05 | zinc acetate | 0.15 | g | O | null |
J01MA03 | pefloxacin | 0.8 | g | P | null |
N01AF01 | methohexital | null | null | null | null |
M01AC | Oxicams | null | null | null | null |
D11AC08 | sulfur compounds | null | null | null | null |
G03AB05 | desogestrel and ethinylestradiol | null | null | null | null |
V09DA05 | technetium (99mTc) galtifenin | null | null | null | null |
M01AC05 | lornoxicam | 12 | mg | R | null |
C09DX03 | olmesartan medoxomil, amlodipine and hydrochlorothiazide | null | null | null | null |
L04AA34 | alemtuzumab | 0.13 | mg | P | null |
G01AF20 | combinations of imidazole derivatives | null | null | null | null |
M02AA03 | clofezone | null | null | null | null |
M01AB03 | tolmetin | 0.7 | g | O | null |
L03AA14 | lipegfilgrastim | 0.3 | mg | P | null |
C02LA52 | rescinnamine and diuretics, combinations with other drugs | null | null | null | null |
R05DB | Other cough suppressants | null | null | null | null |
L04AD02 | tacrolimus | 5 | mg | P | null |
D04AA16 | pheniramine | null | null | null | null |
S01HA02 | oxybuprocaine | null | null | null | null |
N02BA77 | ethenzamide, combinations with psycholeptics | null | null | null | null |
A02BC06 | dexlansoprazole | 30 | mg | O | null |
A01AB21 | chlortetracycline | null | null | null | null |
R03DB05 | aminophylline and adrenergics | null | null | null | null |
V09DA03 | technetium (99mTc) lidofenin | null | null | null | null |
M03AC03 | vecuronium | null | null | null | null |
N03AX03 | sultiame | 0.4 | g | O | null |
J07BF03 | poliomyelitis, trivalent, inactivated, whole virus | null | null | null | null |
A12AA10 | calcium glucoheptonate | 3 | g | O | null |
R03DB06 | etamiphylline and adrenergics | null | null | null | null |
A10BB01 | glibenclamide | 10 | mg | O | null |
C01BA03 | disopyramide | 0.4 | g | O | null |
G01AF19 | sertaconazole | null | null | null | null |
N06BX03 | piracetam | 2.4 | g | O | null |
S01BB03 | fluorometholone and mydriatics | null | null | null | null |
R06AD06 | thiazinam | 0.9 | g | O | null |
A10AB05 | insulin aspart | 40 | U | P | null |
V10XX04 | lutetium (177Lu) oxodotreotide | null | null | null | null |
P01AA05 | tilbroquinol | null | null | null | null |
S01AA09 | tetracycline | null | null | null | null |
S02 | OTOLOGICALS | null | null | null | null |
R06AC | Substituted ethylene diamines | null | null | null | null |
J05AP56 | sofosbuvir, velpatasvir and voxilaprevir | null | null | null | null |
V06DC02 | fructose | null | null | null | null |
V09AX03 | iodine (124I) 2beta-carbomethoxy-3beta-(4 iodophenyl)-tropane | null | null | null | null |
V07A | ALL OTHER NON-THERAPEUTIC PRODUCTS | null | null | null | null |
V08AA09 | methiodal | null | null | null | null |
R01AB07 | oxymetazoline | null | null | null | null |
A06AA | Softeners, emollients | null | null | null | null |
L04AX01 | azathioprine | 0.15 | g | P | null |
N05CA12 | reposal | 0.2 | g | O | null |
C03DB | Other potassium-sparing agents | null | null | null | null |
L01XK05 | veliparib | null | null | null | null |
S03B | CORTICOSTEROIDS | null | null | null | null |
J01FA11 | miocamycin | 1.2 | g | O | null |
G03CA53 | estradiol, combinations | null | null | null | null |
C10AB02 | bezafibrate | 0.6 | g | O | null |
C10AX03 | tiadenol | null | null | null | null |
S01AA10 | natamycin | null | null | null | null |
A02BA06 | roxatidine | 0.15 | g | O | null |
C10AC02 | colestipol | 20 | g | O | null |
M01AA02 | mofebutazone | 0.75 | g | O | null |
V08C | MAGNETIC RESONANCE IMAGING CONTRAST MEDIA | null | null | null | null |
N03AG | Fatty acid derivatives | null | null | null | null |
P02BX02 | niridazole | null | null | null | null |
A10BD25 | metformin, saxagliptin and dapagliflozin | null | null | null | null |
A02AD02 | magaldrate | null | null | null | null |
B01AB04 | dalteparin | 2.5 | TU | P | anti Xa |
J01FA10 | azithromycin | 0.5 | g | P | null |
N06AA | Non-selective monoamine reuptake inhibitors | null | null | null | null |
S01CB | Corticosteroids/antiinfectives/mydriatics in combination | null | null | null | null |
S01BA15 | fluocinolone acetonide | null | null | null | null |
L01BA03 | raltitrexed | null | null | null | null |
D07CB01 | triamcinolone and antibiotics | null | null | null | null |
B01AE05 | ximelagatran | 48 | mg | O | null |
B01AA03 | warfarin | 7.5 | mg | O | null |
M03BC01 | orphenadrine (citrate) | 0.12 | g | O | null |
S02C | CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION | null | null | null | null |
D09AA | Medicated dressings with antiinfectives | null | null | null | null |
A04AA01 | ondansetron | 16 | mg | R | null |
S01CA10 | fluocinolone acetonide and antiinfectives | null | null | null | null |
D07AC21 | ulobetasol | null | null | null | null |
A07AX01 | broxyquinoline | null | null | null | null |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.